收费全文 | 33481篇 |
免费 | 1870篇 |
国内免费 | 146篇 |
耳鼻咽喉 | 373篇 |
儿科学 | 799篇 |
妇产科学 | 578篇 |
基础医学 | 6362篇 |
口腔科学 | 757篇 |
临床医学 | 2644篇 |
内科学 | 6346篇 |
皮肤病学 | 859篇 |
神经病学 | 3457篇 |
特种医学 | 1439篇 |
外科学 | 4624篇 |
综合类 | 162篇 |
一般理论 | 14篇 |
预防医学 | 1687篇 |
眼科学 | 740篇 |
药学 | 2348篇 |
中国医学 | 21篇 |
肿瘤学 | 2287篇 |
2021年 | 360篇 |
2020年 | 296篇 |
2019年 | 500篇 |
2018年 | 585篇 |
2017年 | 445篇 |
2016年 | 577篇 |
2015年 | 667篇 |
2014年 | 796篇 |
2013年 | 1183篇 |
2012年 | 1646篇 |
2011年 | 1768篇 |
2010年 | 1194篇 |
2009年 | 1140篇 |
2008年 | 1904篇 |
2007年 | 1938篇 |
2006年 | 1821篇 |
2005年 | 1931篇 |
2004年 | 1813篇 |
2003年 | 1777篇 |
2002年 | 1867篇 |
2001年 | 357篇 |
2000年 | 283篇 |
1999年 | 390篇 |
1998年 | 505篇 |
1997年 | 417篇 |
1996年 | 368篇 |
1995年 | 339篇 |
1994年 | 290篇 |
1993年 | 259篇 |
1992年 | 221篇 |
1991年 | 218篇 |
1990年 | 185篇 |
1989年 | 177篇 |
1988年 | 189篇 |
1987年 | 148篇 |
1985年 | 164篇 |
1984年 | 189篇 |
1983年 | 169篇 |
1982年 | 205篇 |
1981年 | 179篇 |
1978年 | 140篇 |
1933年 | 170篇 |
1932年 | 180篇 |
1931年 | 167篇 |
1930年 | 169篇 |
1929年 | 147篇 |
1928年 | 163篇 |
1927年 | 144篇 |
1926年 | 158篇 |
1925年 | 139篇 |
Introduction
Preoperative discontinuation of aspirin (acetylsalicylic acid) can reduce bleeding risk but may increase the risk of perioperative cardiovascular events.Materials and methods
We retrospectively assessed the impact of preoperative continuation versus discontinuation of aspirin compared with a control group in a cohort of 739 consecutive patients undergoing total hip (THA) (n = 396) or knee arthroplasty (TKA) (n = 343) at a tertiary hospital. Bleeding risk, local complications, orthopaedic outcome, and cardiac and cerebral complications were assessed.Results
Four hundred and sixty-five patients did not receive antithrombotic or full-dose anticoagulant medication, 175 patients were taking low-dose aspirin, 99 vitamin K antagonists, clopidogrel, or a combination of these drugs. Of the patients taking aspirin, 139 discontinued and 36 continued aspirin. Blood loss and local bleeding complications were comparable in these two groups. TKA patients who continued aspirin more frequently showed marked knee swelling after 1 week than those discontinuing aspirin (35.1 vs. 81.3 %; p = 0.001). However, orthopaedic outcome did not differ significantly between the two groups. There was a trend towards an increased risk of cardiac complications in patients who discontinued aspirin (6.5 vs. 0.0 %; p = 0.107).Conclusions
Continuation or discontinuation of aspirin did not show a statistically significant difference in the risk of relevant perioperative bleeding complications in our study. Continuation of aspirin was associated with a transitory increase in knee swelling, but had no effect on orthopaedic outcome. Continuation of aspirin may be associated with a favourable perioperative cardiac outcome. Our data support perioperative continuation of aspirin intake in patients undergoing THA or TKA.Background
Data on the absorption of orally administered drugs following Roux-en-Y gastric bypass (RYGB) surgery in obese patients are limited and inconclusive. As it is difficult to predict changes in absorption, studies on frequently used drugs in this population are necessary. Acetylsalicylic acid (ASA) and omeprazole are two commonly prescribed drugs in obese patients.Methods
In this repeated measures study, omeprazole and salicylic acid (SA) serum concentrations were measured before and after RYGB in 34 morbidly obese subjects. Time to maximum concentration (Tmax), lag time (Tlag), maximum concentration (Cmax), and area under the serum concentration versus time curve (AUC) were calculated for both drugs to determine possible differences in drug absorption after the procedure.Results
For SA, Tmax significantly decreased after RYGB, while both Cmax and AUC0–24 significantly increased. For omeprazole, both Tmax and Tlag significantly decreased after RYGB, while Cmax significantly increased. Mean AUC0–12 significantly decreased post-surgery. The difference in AUC0–12 before and after surgery varied between subjects.Conclusions
Our study shows a faster absorption of both ASA and omeprazole after RYGB. The exposure to ASA is higher post-surgery, but the standard dose of 80 mg does not need to be modified, considering its range in effective dose. The exposure to omeprazole is, on average, decreased after surgery. Clinicians should be aware to increase the dose of omeprazole if symptoms suggest inadequate response.Material and methods: This retrospective observational study was performed in two large hospitals. Individuals aged between 55 and 75 years with a positive I-FOBT that underwent colonoscopy were included. A detailed family history was obtained in all individuals.
Results: A total of 657 individuals with a positive I-FOBT test underwent colonoscopy. A total of 120 (18.3%) participants were found to have a positive family history for CRC, 20 (3.0%) fulfilled the FCC criteria, 4 (0.6%) the Bethesda guidelines and 1 (0.2%) participant the Amsterdam criteria. Multiple adenomas (>10) were found in 21 (3.2%) participants. No cases of serrated polyposis were identified. Based on these criteria and guidelines, a total of 35 (5.3%) required referral to the clinical geneticist and the relatives of 20 (3.0%) participants should be referred for surveillance colonoscopy.
Conclusion: Obtaining a detailed family history at the time of intake of participants with a positive I-FOBT in the Dutch surveillance program increased the identification of participants with familial CRC. 相似文献
![点击此处可从《Head & neck》网站下载免费的PDF全文](/ch/ext_images/free.gif)